JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.C600293200 on December 19, 2006

J. Biol. Chem., Vol. 282, Issue 6, 3413-3417, February 9, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/6/3413    most recent
C600293200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwashita, S.
Right arrow Articles by Song, S.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwashita, S.
Right arrow Articles by Song, S.-Y.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Versatile Roles of R-Ras GAP in Neurite Formation of PC12 Cells and Embryonic Vascular Development*Formula

Shintaro Iwashita{ddagger}§1, Mariko Kobayashi{ddagger}, Yuya Kubo{ddagger}§, Yoshimi Hinohara{ddagger}, Mariko Sezaki{ddagger}, Kenji Nakamura{ddagger}, Rika Suzuki-Migishima{ddagger}, Minesuke Yokoyama{ddagger}2, Showbu Sato{ddagger}, Mitsunori Fukuda3, Masayuki Ohba{ddagger}, Chieko Kato{ddagger}4, Eijiro Adachi||, and Si-Young Song{ddagger}5

From the {ddagger}Mitsubishi Kagaku Institute of Life Sciences (MITILS), Machida, Tokyo 194-8511, Japan, the §Yokohama National University, Yokohama, Kanagawa 240-8501, Japan, the Brain Science Institute, RIKEN, Wako, Saitama 351-0198, Japan, and the ||Kitasato University School of Medicine, Sagamihara, Kanagawa 228-8555, Japan

Received for publication, November 17, 2006 , and in revised form, December 12, 2006.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Ras GTPase-activating proteins (GAP) are negative regulators of Ras that convert active Ras-GTP to inactive Ras-GDP. R-Ras GAP is a membrane-associated molecule with stronger GAP activity for R-Ras, an activator of integrin, than H-Ras. We found that R-Ras GAP is down-regulated during neurite formation in rat pheochromocytoma PC12 cells by nerve growth factor (NGF), which is blocked by the transient expression of R-Ras gap or dominant negative R-ras cDNA. By establishing a PC12 subclone that stably expresses exogenous R-Ras GAP, it was found that NGF reduced endogenous R-Ras GAP but not exogenous R-Ras GAP, suggesting that down-regulation of R-Ras GAP occurs at the transcription level. To clarify the physiological role of R-Ras GAP, we generated mice that express mutant Ras GAP with knocked down activity. While heterozygotes are normal, homozygous mice die at E12.5–13.5 of massive subcutaneous and intraparenchymal bleeding, probably due to underdeveloped adherens junctions between capillary endothelial cells. These results show essential roles of R-Ras GAP in development and differentiation: its expression is needed for embryonic development of blood vessel barriers, whereas its down-regulation facilitates NGF-induced neurite formation of PC12 cells via maintaining activated R-Ras.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Biochemical reactions mediated by receptors in the plasma membrane not only produce signaling for cell growth and differentiation but also down-regulate this signaling for the maintenance of cellular homeostasis (1). Ras GTPase-activating proteins (GAPs),6 representative molecules responsible for such down-regulation signaling, are negative regulators that convert active Ras-GTP to inactive Ras-GDP (2). Whereas H-Ras is a central regulator of cell proliferation and differentiation, R-Ras is an activator of integrins, cell-surface receptors for the extracellular matrix (3). R-Ras and H-Ras exert opposite effects on integrin activation (4), thus producing different effects, for example, on the interaction between endothelial cells and monocytes (5). Activated H-Ras, but not R-Ras, induces extensive neuronal differentiation of rat pheochromocytoma PC12 cells (6), while dominant active R-Ras promotes neurite outgrowth of late embryonic retinal neurons (7). For the proper formation of the neuronal network, R-Ras inactivation is also required to induce growth cone collapse via the R-Ras GAP activity of plexin-B1, a Semaphorin 4D receptor (8). These results implicate the need for a balance between R-Ras and H-Ras activation/inactivation in long term biological processes such as neuronal differentiation and homeostasis.

Four types of Ras GAPs have been identified (9), and targeted mice have been generated for three of them. Null mice of p120gap (10) or Nf1 (neurofibromin) (11, 12) are embryonic lethal apparently due to defects in the higher organization of endothelial and neuronal cells. Mutant mice of Syngap, a brain-specific Ras gap, are postnatal lethal apparently due to improper neuronal development (13). The fourth type, GAP1 family members (9), share conserved domains: tandem C2 domains, a GAP-related domain (GRD), and a pleckstrin homology domain. R-Ras GAP (also called GAP1IP4BP), a member of the fourth family, is membrane-associated (14) and has a stronger GAP activity against R-Ras than H-Ras (15). An arginine situated in the GRD loop, the "arginine finger," has been identified as essential for all Ras GAP activity (16). Based on this result, we generated mice mutant for R-Ras gap, which lacks the region including the arginine finger, to clarify its physiological significance in vivo. In this paper, we show a positive correlation between the down-regulation of R-Ras GAP and neurite outgrowth of PC12 cells and the embryonic lethality of R-Ras gap mutant mice accompanied with massive hemorrhage.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
All experimental procedures are described in the supplemental data.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Positive Correlation between the Down-regulation of R-Ras GAP and Neurite Outgrowth of PC12 Cells—We examined transcript levels of three Ras gap (R-Ras gap, p120gap, and Nf1) by quantitative RT-PCR in nerve growth factor (NGF)-treated PC12D cells. R-Ras gap transcript levels decreased by about 80% after treatment with NGF for 20 h, when neurites are substantially extended. Epidermal growth factor (EGF), a growth-promoting factor in PC12 cells, had no effect (Fig. 1A). A reduction in the R-Ras gap transcript was also induced by another differentiating reagent, 8-(4-chlorophenylthio) cAMP (CPTcAMP) (Fig. 1A). On the other hand, the amounts of p120gap or Nf1 transcripts showed little change by treatment with NGF (Table 1). After incubation with NGF for 4 days, the R-Ras gap transcript returned to initial levels. Northern blot analysis confirmed the NGF-mediated suppression of R-Ras gap mRNA (Fig. 1B). The amount of R-Ras GAP protein was also decreased by NGF, but not EGF, whereas that of p120GAP was unchanged (Fig. 1C and supplemental Fig. 1C). These results show a good correlation between the down-regulation of R-Ras GAP and neurite outgrowth of PC12D cells.


Figure 1
View larger version (37K):
[in this window]
[in a new window]

  		FIGURE 1.
Positive correlation between down-regulation of R-Ras GAP and neurite outgrowth of PC12 cells. A, measurement of Ras gap transcripts. The transcript levels of R-Ras gap were measured by quantitative RT-PCR in PC12 cells treated with NGF (20 ng/ml), EGF (10 ng/ml), or CPTcAMP (0.25 mM). The mean values ± S.E. are shown with the number of independent experiments in parentheses. B, Northern bolt analysis. One mg of total RNA from rat brain or PC12D cells treated with or without NGF for 24 h was analyzed using a R-Ras gap cRNA probe. C, immunoblot analysis. Immunoprecipates obtained with anti-R-Ras GAP peptide #2 Ab were separated by a two-dimensional gel electrophoresis followed by immunoblotting. Panels a–c, rat brain (a) and PC12 cells untreated (b) or treated with NGF (c) are shown. D and E, analysis of neurite formation. The indicated amounts of R-ras (V38), R-ras (N43), R-Ras gap, or H-ras (N17) cDNA were co-transfected into PC12D cells with green fluorescence protein vector. After culturing for 2 days, cells were incubated in the presence of NGF for 2 days (D) or 1 day (E). Green fluorescence protein-positive cells were scored as bearing neurites, if they had processes two times longer than the diameter of the cell body. Each value represents the mean ± S.E. of multiple independent experiments as indicated by the number in parentheses (D) or in triplicate (E).

 


View this table:
[in this window]
[in a new window]

  		TABLE 1
Down-regulation of the R-Ras gap transcript by neurite forming reagents

RNAs were prepared from PC12D cells cultured in the presence of NGF, EGF, or CPTcAMP for 20 h. Quantitative RT-PCR was carried out using specific primers for each Ras gap transcript (supplemental Table 1). Changes in the levels of each transcript induced by ligand are expressed relative to that of glyceraldehyde-3-phosphate dehydrogenase measured in each case as an internal control and expressed as 100. The mean values ± S.E. are shown with the number of independent experiments in parentheses, ND, not done.

 
To address the biological significance of R-Ras GAP down-regulation in neurite outgrowth, we employed transient transfection experiments to examine the effects of Ras or Ras GAP on NGF-mediated neurite outgrowth of PC12 cells. Whereas dominant positive R-ras (V38) rather enhanced outgrowth, dominant negative R-ras (N43) significantly inhibited neurite outgrowth in a dose dependent manner (Fig. 1D). Furthermore, transfection of R-Ras gap cDNA substantially suppressed neurite outgrowth similarly to H-ras (N17), a dominant negative H-Ras, a blocker of neuronal differentiation of PC12 cells (17) (Fig. 1E). These results imply that the down-regulation of R-Ras GAP is relevant to the long-term activation of R-Ras, which seems to be critical for neurite outgrowth of PC12D cells. To examine which step the down-regulation of R-Ras GAP occurs, we established a PC12D subclone that stably expressed FLAG-tagged R-Ras GAP. Because exogenous R-Ras GAP with a FLAG tag (DYK-DDDDK) is bigger than endogenous R-Ras GAP by 1 kDa of molecular size and has an extra three negative charges, the two R-Ras GAPs can be distinguished by two-dimensional analysis of Western blotting. The exogenous R-Ras GAP was found to be much more resistant to NGF treatment than the endogenous R-Ras GAP (supplemental Fig. 2), suggesting that down-regulation of R-Ras GAP was regulated at the transcriptional level.

High Expression of R-Ras gap mRNA in the Brain and Spleen—The tissue distribution of the R-Ras gap transcript was examined using a specific cRNA probe. The mRNA was detected at high levels in the brain and spleen of 4-day-old rats, and high expression was maintained in the brain of 4-week-old rats (supplemental Fig. 3A). On the other hand, gap1m (18), a structurally related Ras gap, expressed rather ubiquitously in these tissues (data not shown). We next examined the cellular distribution of the R-Ras gap transcript in 4-week-old rat brain by in situ hybridization (supplemental Fig. 3B). The signals were distributed ubiquitously in all layers of the cerebral cortex but not in the white matter. In the cerebellum, the signal was strong in the Purkinje cell layer and moderate in the granule cell layer but not present in the white matter. In the olfactory bulb, the signal was strong in the mitral cell and glomerular layers and moderate in the granule cell layer. In the hippocampal region, the CA regions and dentate gyrus showed strong signals. These results show that R-Ras gap is highly expressed in the brain, mainly in neuronal cells.

Generation and Characterization of R-Ras gap Mutant Mice—To explore further the physiological role of R-Ras GAP in vivo, we tried to generate R-Ras gap mutant mice. The gene comprises 24 exons with its GRD in exons 10–16 (Fig. 2A-1). An arginine located in exon 12 (arginine finger) is critical for Ras GAP activity (16). To generate mutant mice with knocked down R-Ras GAP activity, a targeting vector was constructed by replacing exons 11–12 with Neo cassette. Since these exons consist of 149 and 115 nucleotides, respectively, the transcript of the targeted R-Ras gap should lack 264 nucleotides corresponding to 88 amino acids without frameshift (see Fig. 2C). Southern blot, RT-PCR, and immunoblot analyses gave results consistent with those of the truncated form of R-Ras GAP: deletion of an allele, expression of spliced mRNA, and truncated GAP protein of the predicted size (Fig. 2, A–C). So far more than 150 heterozygotes have been bred, and all have grown normally with average life span, indicating that the truncated R-Ras GAP molecule does not interfere with proper Ras signaling. However, no viable R-Ras gap–/– offspring were born from R-Ras gap+/– intercrosses, raising the possibility that R-Ras gap is essential for embryonic development. We found that homozygotes die at E12.5–13.5. All homozygotes, more than 50, dissected at E13.5 showed massive subcutaneous and intraparenchymal bleeding, while no heterozygotes showed such findings. Some homozygote embryos dissected at E12.5 showed hemorrhaging in the brain and/or rump (Fig. 3A). No apparent macroscopic or microscopic abnormalities were noted in systemic organs at E12.5. Furthermore, no increased apoptosis and neural degeneration were observed in homozygotes of R-Ras gap embryo (data not shown), which were described in p120gap KO mice (10). Then, because R-Ras gap is highly expressed in the brain, and severe hemorrhaging occurs frequently in the brains of homozygotes, we examined brain blood vessels by electron microscopy. We observed that the adherens junctions between capillary endothelial cells were less developed in homozygotes as compared with heterozygous or wild-type mice (Fig. 3B). Thus, the possible explanation for the massive hemorrhaging in homozygotes is increased permeability of blood vessels due to underdeveloped adherens junctions between endothelial cells as detected in the brain. We could not examine the effects of loss of function of R-Ras GAP on the neurite formation due to the embryonic lethality of mutant mice.


Figure 2
View larger version (33K):
[in this window]
[in a new window]

  		FIGURE 2.
Generation of R-Ras gap mutant mice. A-1, targeting vector. The top panel represents the relationship between exons and domains of R-Ras gap. A targeting vector was constructed by replacing the region of exons 11–12 with Neo cassette and by the addition of the diphtheria toxin A (DT-A) cassette. A-2, Southern blot analysis. Genomic DNA digested with KpnI was analyzed using an external 3' probe (indicated in A-1). A 9.1- or 14.9-kb band is detected from wild-type or targeted allele, respectively. Abbreviations: +/+; wild type; +/–, R-Ras gap, heterozygotes; –/–, R-Ras gap homozygotes. A-3, genotyping of mice. PCR of genomic DNA from littermates was carried out using two sets of primers. Pooled PCR products were stained with ethidium bromide after separation in agarose gels. The upper and the lower bands denote products from the targeted allele and the wild-type allele, respectively. B, expression of spliced transcripts. The top panel represents a schematic presentation of transcripts and three expected PCR products with their sizes (bp). RT-PCR was performed using three sets of primers (supplemental Table 1) and total RNA from E12.5 of wild-type, heterozygote, or homozygote mice as indicated. M, size marker. C, truncated R-Ras GAP protein. Whole-brain lysates of wild-type (left) or heterozygote (right) mice were immunoprecipitated and followed by immunoblotting. The arrows indicate expected bands of wild-type (97 kDa) and truncated R-Ras GAP (88 kDa), respectively. The bar in the upper panel denotes the location of peptide#2 for Ab production.

 


Figure 3
View larger version (81K):
[in this window]
[in a new window]

  		FIGURE 3.
Phenotypes of R-Ras gap mutant mice. A, photographs of E12.5 embryos of R-ras gap homozygotes (–/–), heterozygotes (+/–), and wild-type (+/+) littermates, whose genotypes were determined by genomic PCR. Homozygotes exhibited edema and hemorrhaging in the head and trunk. B, transmission electron micrographs of adherens junctions between endothelial cells of the brain from wild-type (left) and homozygote (right) mice. The right side corresponds to a lumen of the blood vessel. Arrows indicate junctions between capillary endothelial cells. Note that the number of adherens junctions in homozygotes is greatly reduced.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
In this study we demonstrate that homozygous R-Ras gap mutant mice are embryonic lethal dying at E12.5–13.5. Mouse embryo fibroblasts established from the mutant mice dissected at E8.5 grow normally compared with those from heterozygotes and wild-type (data not shown), indicating that R-Ras gap is not essential for cell growth. The homozygote mice showed massive subcutaneous and intraparenchymal bleeding, probably due to underdeveloped adherens junctions between capillary endothelial cells. This phenotype is related to reports that p120gap (10) and Nf1 (11, 12) null mice are also embryonic lethal dying at E9 or E13.5–14.5 and show severe defects in the higher organization of endothelial cells in the vascular system and neuronal cells in the brain. Therefore, these Ras gap mutant mice may share a common defect involving abnormal migration or adhesiveness or organization of endothelial cells. Our R-Ras gap mutant mice lacked 88 amino acids, including the arginine finger loop responsible for both catalytic activity (16) and substrate specificity (19). Replacement of the arginine with lysine in p120GAP GRD results in a 1000th reduction in Ras GAP activity (16), suggesting that our mutant mice have the low Ras GAP activity of truncated R-Ras GAP. Because R-Ras GAP is a constitutively membrane-associated molecule, and all Ras signaling occurs only in plasma membrane, the knockdown of R-Ras GAP activity may lead to long-term activated R-Ras.

It has been established that R-Ras is mainly responsible for cell adhesiveness and H-Ras for cell migration (4), but many ras null mice are non-lethal with the exception of K-ras null mice (20). In non-lethal mice, such as H-ras null mice (21) and N-ras null mice (22), total levels of Ras protein (Pan Ras) are maintained as in wild-type mice. R-ras null mice are phenotypically normal with excessive vascular formation (23). These results indicate the mutual signaling networks and compensation among Ras family members. In contrast, the number of Ras GAP molecules is limited compared with Ras members, and all null or mutant mice of Ras GAP members generated so far are unviable. The lethality might be related to the broad substrate specificity of Ras GAP molecules. R-Ras GAP (15) and p120GAP (24) have stronger GAP activities for R-Ras than H-Ras, whereas NF1 has stronger GAP activity for H-Ras than R-Ras. Furthermore, Cullen and co-workers (9) have reported that R-Ras GAP and Ca+2-triggered Ras GAPs have GAP activity for Rap in addition to a proper target Ras. Therefore knockdown of a Ras GAP molecule may lead to the long term activation of related-Ras molecules as well as one target Ras, resulting in wider aberrant Ras signaling that cannot be compensated for by the mutual Ras network mentioned above.

It is noteworthy that R-Ras stimulates, whereas H-Ras inhibits, the interaction between monocytes and endothelial cells (5), which facilitates transmigration of monocytes across endothelial cells (25). These results suggest the importance of a balance between R-Ras and H-Ras activation in blood barrier homeostasis. Although it is not evident how R-Ras GAP is directly involved in the organization of adherens junctions during development, the blood vessel leakiness of mutant mice at E12.5 (Fig. 3A) might be induced by an imbalance between R-Ras and H-Ras activation. In our homozygote mice, this imbalance is caused by maintaining activated R-Ras and other Ras-related molecules due to a lack of proper R-Ras GAP. Massive hemorrhaging first detected at E12.5 seems to be closely related to the fact that cardiac ventricular pressure in mouse embryos increases significantly around embryonic day 12 (26). The blood barrier of the mutant mice may not endure the increased blood pressure. We did not examine the embryos earlier than E12.5 with respect to the changes in the brain. However, concerning the changes in the adherens junction, the detailed analysis on earlier embryos remains to be clarified.

We show a positive correlation between differentiation factor-mediated down-regulation of R-Ras GAP, but not p120GAP, and neurite outgrowth of PC12 cells (Fig. 1, A–C). The down-regulation of R-Ras GAP may maintain long term activation of not only R-Ras but also Ras-related proteins, which may facilitate the NGF-mediated differentiation of PC12 cells similar to the outgrowth of retinal neurons (7). It is noteworthy that the down-regulation of R-Ras GAP, a negative regulator, may mediate slow and long positive signaling such as NGF-mediated neuronal differentiation of PC12 cells. This type of signaling may fulfill the requirements for the differentiation process where a constitutive stimulation occurs, while cellular homeostasis is maintained. So far we cannot explain the two critical functions of R-Ras GAP from a collective view: its expression is essential for blood barrier homeostasis, whereas its down-regulation may facilitate neurite formation of PC12 cells. We expect to reveal a new aspect of signaling networks by clarifying the mechanism by which the balance in the activation of R-Ras, H-Ras, and other Ras-related molecules is maintained. The mechanism is involved in long term processes such as neuronal differentiation and homeostasis.


   FOOTNOTES
 
* This work was supported in part by a grant from the Japanese Ministry of Health and Welfare. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Formula The on-line version of this article (available at http://www.jbc.org) contains the "Experimental Procedures" and supplemental Figs. 1–3 and Table 1. Back

2 Present address: Niigata University, Niigata, Niigata 951-8585, Japan. Back

3 Present address: Tohoku University, Sendai, Miyagi 980-8578, Japan. Back

4 Present address: Tokushima Bunri University, Sanuki, Kagawa 769-2193, Japan. Back

1 To whom correspondence may be addressed. Present address: Iwaki Meisei University, 5-5-1 Chuodai Iino, Iwaki City, Fukushima 970-8551, Japan. Tel.: 81-246-29-7165; E-mail: siwast{at}iwakimu.ac.jp. 5 To whom correspondence may be addressed. Present address: Tokushima Bunri University, Sanuki, Kagawa 769-2193, Japan. Tel.: 81-87-894-5111 (ext. 6805); Fax: 81-87-894-0181; E-mail: sysong{at}kph.bunri-u.ac.jp.

6 The abbreviations used are: GAP, GTPase-activating protein; NGF, nerve growth factor; EGF, epidermal growth factor; CPTcAMP, 8-(4-chlorophenylthio) cAMP; p120GAP, a 120-kDa GAP with SH2/SH3 domains; NF1, neurofibromatosis type-1 gene product; GRD, GAP-realted domain; RT, reverse transcription; Ab, antibody. Back


   ACKNOWLEDGMENTS
 
We thank M. Sano for providing PC12D cells; T. Yamakuni, A. Oomori, S. Kamijo, S. Ichinose, and S. Omichi for technical advice; T. Saitoh for help in electron microscopic analysis; and S. Konishi, H. Koide, J. Suzuki, S. Hattori, and Y. Konishi for discussion. We are indebted to M. Dooley-Ohto, K. K. Chada, and K. K. Iwata for editing the manuscript.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Iwashita, S., and Kobayashi, M. (1992) Cell. Signal. 4, 123–132[CrossRef][Medline] [Order article via Infotrieve]
  2. Donovan, S., Shannon, K. M., and Bollag, G. (2002) Biochim. Biophys. Acta. 1602, 23–45[Medline] [Order article via Infotrieve]
  3. Zhang, Z., Vuori, K., Wang, H. G., Reed, J. C., and Ruoslahti, E. (1996) Cell 85, 61–69[CrossRef][Medline] [Order article via Infotrieve]
  4. Kinbara, K., Goldfinger, L. E., Hansen, M., Chou, F. L., and Ginsberg, M. H. (2003) Nat. Rev. Mol. Cell Biol. 4, 767–778[Medline] [Order article via Infotrieve]
  5. Cole, A. L., Subbanagounder, G., Mukhopadhyay, S., Berliner, J. A., and Vora, D. K. (2003) Arterioscler. Thromb. Vasc. Biol. 23, 1384–1390[Abstract/Free Full Text]
  6. Self, A. J., Caron, E., Paterson, H. F., and Hall, A. (2001) J. Cell Sci. 114, 1357–1366[Abstract]
  7. Ivins, J. K., Yurchenco, P. D., and Lander, A. D. (2000) J. Neurosci. 20, 6551–6560[Abstract/Free Full Text]
  8. Ito, Y., Oinuma, I., Katoh, H., Kaibuchi, K., and Negishi, M. (2006) EMBO Rep. 7, 704–709[CrossRef][Medline] [Order article via Infotrieve]
  9. Kupzig, S., Deaconescu, D., Bouyoucef, D., Walker, S. A., Liu, Q., Polte, C. L., Daumke, O., Ishizaki, T., Lockyer, P. J., Wittinghofer, A., and Cullen, P. (2006) J. Biol. Chem. 281, 9891–9900[Abstract/Free Full Text]
  10. Henkemeyer, M., Rossi, D. J., Holmyard, D. P., Puri, M. C., Mbamalu, G., Harpal, K., Shih, T. S., Jacks, T., and Pawson, T. (1995) Nature 377, 695–701[CrossRef][Medline] [Order article via Infotrieve]
  11. Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., and Copeland, N. G. (1994) Genes Dev. 8, 1019–1029[Abstract/Free Full Text]
  12. Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., and Weinberg, R. A. (1994) Nat. Genet. 7, 353–361[CrossRef][Medline] [Order article via Infotrieve]
  13. Kim, J. H., Lee, H. K., Takamiya, K., and Huganir, R. L. (2003) J. Neurosci. 23, 1119–1124[Abstract/Free Full Text]
  14. Cozier, G. E., Lockyer, P. J., Reynolds, J. S., Kupzig, S., Bottomley, J. R., Millard, T. H., Banting, G., and Cullen, P. J. (2000) J. Biol. Chem. 275, 28261–28268[Abstract/Free Full Text]
  15. Yamamoto, T., Matsui, T., Nakafuku, M., Iwamatsu, A., and Kaibuchi, K. (1995) J. Biol. Chem. 270, 30557–30561[Abstract/Free Full Text]
  16. Ahmadian, M. R., Kiel, C., Stege, P., and Scheffzek, K. (2003) J. Mol. Biol. 329, 699–710[CrossRef][Medline] [Order article via Infotrieve]
  17. Szeberenyi, J., Cai, H., and Cooper, G. M. (1990) Mol. Cell Biol. 10, 5324–5332[Abstract/Free Full Text]
  18. Maekawa, M., Li, S., Iwamatsu, A., Morishita, T., Yokota, K., Imai, Y., Kohsaka, S., Nakamura, S., and Hattori, S. (1994) Mol. Cell. Biol. 14, 6879–6885[Abstract/Free Full Text]
  19. te Biesebeke, R., Krab, I. M., and Parmeggiani, A. (2001) Biochemistry 40, 7474–7479[Medline] [Order article via Infotrieve]
  20. Koera, K., Nakamura, K., Nakao, K., Miyoshi, J., Toyoshima, K., Hatta, T., Otani, H., Aiba, A., and Katsuki, M. (1997) Oncogene 15, 1151–1159[CrossRef][Medline] [Order article via Infotrieve]
  21. Ise, K., Nakamura, K., Nakao, K., Shimizu, S., Harada, H., Ichise, T., Miyoshi, J., Gondo, Y., Ishikawa, T., Aiba, A., and Katsuki, M. (2000) Oncogene. 19, 2951–2956[CrossRef][Medline] [Order article via Infotrieve]
  22. de Castro, I. P., Diaz, R., Malumbres, M., Hernandez, M. I., Jagirdar, J., Jimenez, M., Ahn, D., and Pellicer, A. (2003) Cancer Res. 63, 1615–1622[Abstract/Free Full Text]
  23. Komatsu, M., and Ruoslahti, E. (2005) Nat. Med. 11, 1346–1350[CrossRef][Medline] [Order article via Infotrieve]
  24. Li, S., Nakamura, S., and Hattori, S. (1997) J. Biol. Chem. 272, 19328–19332[Abstract/Free Full Text]
  25. Ridley, A. J. (2001) FEBS Lett. 498, 168–171[CrossRef][Medline] [Order article via Infotrieve]
  26. Ishiwata, T., Nakazawa, M., Pu, W. T., Tevosian, S. G., and Izumo, S. (2003) Circ. Res. 93, 857–865[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/6/3413    most recent
C600293200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwashita, S.
Right arrow Articles by Song, S.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwashita, S.
Right arrow Articles by Song, S.-Y.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.